Text Size

Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies

Nguyen Q.D., Merrill P.T., Sepah Y.J., Ibrahim M.A., Banker A., Leonardi A., Chernock M., Mudumba S., Do D.V.


  • 2018
  • Ophthalmology
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Categories

    Preclinical development

  • Affiliations

    Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, United States; Department of Ophthalmology, Rush University Medical Center, Chicago, IL, United States; Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, United States; Banker's Retina Clinic and Laser Center, Navrangpura, Ahmedabad, India; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Santen, Inc., Emeryville, CA, United States; Ocular Imaging Research and Reading Center (OIRRC), Menlo Park, CA, United States

Related Publications

Low-Dose Atropine and Other Interventions for Pediatric Myopia: A Systematic Review and Bayesian Network Meta-analysis of Efficacy and Post-treatment Outcomes

Jovanović J., Zacharioudaki M., Kalatzi M., Papadakis G., Mulkalapalli N., Ernst F., de Milliano T.


Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

Shi-van Wielink K., Dahlmann-Noor A., Li J., de Milliano T.W.L., Ernst F., Croci F., Sharma Y., Punekar Y.


Two-year prospective natural history study of EYS-associated retinitis pigmentosa using adaptive optics: the KEYS study

Masakazu H., Akiko M., Midori Y., Elena G.-S., Shohei K., Satoshi Y., Yuki T., Masanao T., Shuhei K., Yasuhiko H., Yasuo K., Kiyoko G.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022